Section Arrow
Quote
MLTX.NASDAQ
- MoonLake Immunotherapeutics
Quotes are at least 15-min delayed:2025/09/12 04:15 EDT
Pre Market
Last
 --
-- (--)
Bid
52.42
Ask
85.8
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 54.3
+0.1 (+0.18%)
Day High 
55.385 
Prev. Close
54.2 
1-M High
61.87 
Volume 
706.08K 
Bid
52.42
Ask
85.8
Day Low
52.67 
Open
53.79 
1-M Low
51.74 
Market Cap 
3.44B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 57.55 
20-SMA 56.01 
50-SMA 53.4 
52-W High 61.87 
52-W Low 31.4201 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.79/-3.46
Enterprise Value
3.44B
Balance Sheet
Book Value Per Share
5.57
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
GRIGRI Bio Inc.2.05+0.49+31.41%0.02PE
Pre Market 1.78 -0.27 -13.17%
RXRXRecursion Pharmaceuticals4.85+0.31+6.83%-- 
Pre Market 4.92 +0.07 +1.44%
SLXNSilexion Therapeutics Corp4.93+0.445+9.92%-- 
Pre Market 4.91 -0.02 -0.41%
ADAPAdaptimmune Therapeutics plc0.0505-0.0003-0.59%-- 
Pre Market 0.0515 +0.001 +1.98%
ROIVRoivant Sciences Ltd14.41+0.64+4.65%1.95PE
Pre Market 14.41 0 0.00%
Quotes are at least 15-min delayed：2025/09/12 04:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.